Making the Switch: Benefits of New Intravenous TPN Lipid Emulsion in Critically Ill Patients

Learning objectives:

• Discuss new, next-generation parenteral nutrition (PN) lipid formulations currently available, including differences in composition
• Explore evidence for use of new PN lipid formulations in critically ill adult and pediatric patients to improve outcomes
• Examine new data for benefits of switching from intralipid to new PN lipid formulations from large institutional clinical outcomes study in adult and pediatric ICU patients
• Discuss rationale, pathway, and key evidence for proposing or justifying conversion to new PN lipid formulation in your institution

SCCM offers various sponsorship and advertising opportunities for industry partners to promote their brand launches or current therapies, conduct a focused program on disease awareness, or discuss their current pipeline activity.

The views and opinions expressed are those of the speakers and do not necessarily reflect the views or opinions of SCCM. References to specific commercial entities, products, tests, procedures, opinions, resources, and information do not reflect SCCM’s review or endorsement.